INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2019

Vitamin D supplementation was not associated with reduced major adverse cardiovascular events or all-cause mortality in a meta-analysis of 21 RCTs.

A meta-analysis of 21 randomized clinical trials evaluated the effect of long-term (≥1 year) vitamin D supplementation in 83,291 participants (41,669 receiving vitamin D, 41,622 receiving placebo). Vitamin D supplementation was not associated with reduced major adverse cardiovascular events (RR, 1.00; 95% CI, 0.95-1.06; P = .85) or all-cause mortality (RR, 0.97; 95% CI, 0.93-1.02; P = .23). No significant reductions were seen for myocardial infarction (RR, 1.00; 95% CI, 0.93-1.08), stroke (RR, 1.06; 95% CI, 0.98-1.15), or CVD mortality (RR, 0.98; 95% CI, 0.90-1.07). The abstract notes that only 4 trials prespecified CVD as a primary endpoint.

Study type
Meta-analysis of randomized clinical trials
Who was studied
83,291 participants across 21 RCTs (mean age 65.8 years, 74.4% female)
What was measured
Major adverse cardiovascular events, myocardial infarction, stroke, CVD mortality, and all-cause mortality

THE PAPER

Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis.

Barbarawi M, Kheiri B, Zayed Y, Barbarawi O, Dhillon H, Swaid B, Yelangi A, Sundus S, Bachuwa G, Alkotob ML, Manson JE. JAMA Cardiol, 2019.

PubMed 31215980 ↗DOI 10.1007/s11064-014-1316-0 ↗

Heart & arteries

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.